Antioxidants in Patients Treated for Cancer
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
For our patients undergoing cancer treatment, what role do antioxidant substances play? Further, should we encourage or actively discourage these patients from taking them? Dr. Brian Lawenda, assistant professor of radiation oncology at the Indiana University School of Medicine, discusses the rationale for and against the use of antioxidants in patients receiving both chemotherapy and radiation therapy with your host, Dr. Lee Freedman.
Overview
For our patients undergoing cancer treatment, what role do antioxidant substances play? Further, should we encourage or actively discourage these patients from taking them? Dr. Brian Lawenda, assistant professor of radiation oncology at the Indiana University School of Medicine, discusses the rationale for and against the use of antioxidants in patients receiving both chemotherapy and radiation therapy with your host, Dr. Lee Freedman.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Digital Therapeutics Clinical Trials: From Design to Data Interpretation
Engaging Patients and Caregivers About Digital Therapeutics
FCS and SHTG: Are We Meeting the Need?
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
Optimizing PPD Diagnosis and Treatment: The Role of Neuroactive Steroids and Multidisciplinary Care
HF Management for Patients with Comorbid Conditions
Level Up Your Skills: Tailoring Management of HF
Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?